A Cleveland Clinic research team has discovered how a protein on the surface of immune system mast cells in the lungs facilitates the cells’ proliferation, contributing to severe inflammation and progression to asthma. Although more research is needed to fully understand mast cell hyperproliferation, inhibiting the surface protein known as MCEMP1 could be a new approach to treating asthma and other inflammatory lung conditions.